Ex-biopharmaceutical employees convicted in U.S. of insider trading


BOSTON (Reuters) – Two former employees of rival biopharmaceutical companies were convicted on Tuesday on U.S. charges that they used their access to confidential information about drug studies to profit in the stock market through insider trading.

Former Akebia Therapeutics Inc employee Schultz Chan (L) and his lawyer, Peter Horstmann, exit the federal courthouse in Boston, Massachusetts, U.S. July 10, 2018. REUTERS/Nate Raymond

A federal jury in Boston found Schultz Chan, a former Akebia Therapeutics Inc employee, and Songjiang Wang, who worked at Merrimack Pharmaceuticals Inc, guilty on…



Read More Here

Be the first to comment on "Ex-biopharmaceutical employees convicted in U.S. of insider trading"

Leave a comment

Your email address will not be published.


*